Found 4 results
Filters: Author is X.B. Wang  [Clear All Filters]
X. F. Chen, Cai, S., Chen, Q. G., Ni, Z. H., Tang, J. H., Xu, D. W., and Wang, X. B., Multiple variants of TERT and CLPTM1L constitute risk factors for lung adenocarcinoma, vol. 11, pp. 370-378, 2012.
Boezen HM (2009). Genome-wide association studies: what do they teach us about asthma and chronic obstructive pulmonary disease? Proc. Am. Thorac. Soc. 6: 701-703. PMid:20008879 Caporaso N, Gu F, Chatterjee N, Sheng-Chih J, et al. (2009). Genome-wide and candidate gene association study of cigarette smoking behaviors. PLoS One 4: e4653. PMid:19247474    PMCid:2644817 Chen WQ (2009). Estimation of cancer incidence and mortality in China in 2004-2005. Zhonghua Zhong. Liu Za Zhi. 31: 664-668. PMid:20021861 Chung CC, Magalhaes WC, Gonzalez-Bosquet J and Chanock SJ (2010). Genome-wide association studies in cancer-current and future directions. Carcinogenesis 31: 111-120. PMid:19906782    PMCid:2860704 Easton DF and Eeles RA (2008). Genome-wide association studies in cancer. Human Mol. Genet. 17: R109-115. PMid:18852198 Fernandez-Garcia I, Ortiz-de-Solorzano C and Montuenga LM (2008). Telomeres and telomerase in lung cancer. J. Thorac. Oncol. 3: 1085-1088. PMid:18827602 Gu D, Kelly TN, Wu X, Chen J, et al. (2009). Mortality attributable to smoking in China. N. Engl. J. Med. 360: 150-159. PMid:19129528 Helland A and Brustugun OT (2009). Lung cancer in smokers and never-smokers. Tidsskr. Nor. Laegeforen. 129: 1859-1862. PMid:19844277 Hsiung CA, Lan Q, Hong YC, Chen CJ, et al. (2010). The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet. 6. Jin G, Xu L, Shu Y, Tian T, et al. (2009). Common genetic variants on 5p15.33 contribute to risk of lung adenocarcinoma in a Chinese population. Carcinogenesis 30: 987-990. PMid:19369581 Kang JU, Koo SH, Kwon KC, Park JW, et al. (2008). Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer. Cancer Genet. Cytogenet. 182: 1-11. Landi MT, Chatterjee N, Yu K, Goldin LR, et al. (2009). A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am. J. Hum. Genet. 85: 679-691. PMid:19836008    PMCid:2775843 Maser RS, Choudhury B, Campbell PJ, Feng B, et al. (2007). Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature 447: 966-971. PMid:17515920    PMCid:2714968 McKay JD, Hung RJ, Gaborieau V, Boffetta P, et al. (2008). Lung cancer susceptibility locus at 5p15.33. Nat. Genet. 40: 1404-1406. PMid:18978790    PMCid:2748187 Metzger R, Vallbohmer D, Muller-Tidow C, Higashi H, et al. (2009). Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer. Anticancer Res. 29: 1157-1162. PMid:19414359 Molina JR, Yang P, Cassivi SD, Schild SE, et al. (2008). Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin. Proc. 83: 584-594. PMid:18452692    PMCid:2718421 Nishio Y, Nakanishi K, Ozeki Y, Jiang SX, et al. (2007). Telomere length, telomerase activity, and expressions of human telomerase mRNA component (hTERC) and human telomerase reverse transcriptase (hTERT) mRNA in pulmonary neuroendocrine tumors. Jpn. J. Clin. Oncol. 37: 16-22. PMid:17060405 Perera SA, Maser RS, Xia H, McNamara K, et al. (2008). Telomere dysfunction promotes genome instability and metastatic potential in a K-ras p53 mouse model of lung cancer. Carcinogenesis 29: 747-753. PMid:18283039 Rafnar T, Sulem P, Stacey SN, Geller F, et al. (2009). Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat. Genet. 41: 221-227. PMid:19151717 Reguart N, Cardona AF, Carrasco E, Gomez P, et al. (2008). BRCA1: a new genomic marker for non-small-cell lung cancer. Clin. Lung Cancer 9: 331-339. PMid:19073515 Sreeja L, Syamala V, Raveendran PB, Santhi S, et al. (2008). p53 Arg72Pro polymorphism predicts survival outcome in lung cancer patients in Indian population. Cancer Invest. 26: 41-46. PMid:18181044 Stinchcombe TE and Socinski MA (2009). Current treatments for advanced stage non-small cell lung cancer. Proc. Am. Thorac. Soc. 6: 233-241. PMid:19349493 Strazisar M, Mlakar V, Rott T and Glavac D (2009). Somatic alterations of the serine/threonine kinase LKB1 gene in squamous cell (SCC) and large cell (LCC) lung carcinoma. Cancer Invest. 27: 407-416. PMid:19229701 Sun Y (1987). The epidemiology, etiology and carcinogenesis of lung cancer. Beijing Med. 10: 56. Svejgaard A, Hauge M, Jersild C, Platz P, et al. (1975). The HLA system. An introductory survey. Monogr. Hum. Genet. 7: 1-100. PMid:55961 Thomas G, Jacobs KB, Yeager M, Kraft P, et al. (2008). Multiple loci identified in a genome-wide association study of prostate cancer. Nat. Genet. 40: 310-315. PMid:18264096 Wang Y, Broderick P, Webb E, Wu X, et al. (2008). Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat. Genet. 40: 1407-1409. PMid:18978787    PMCid:2695928 Wang Y, Broderick P, Matakidou A, Eisen T, et al. (2010). Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers. Carcinogenesis 31: 234-238. PMid:19955392 Yamamoto K, Okamoto A, Isonishi S, Ochiai K, et al. (2001). A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. Biochem. Biophys. Res. Commun. 280: 1148-1154. PMid:11162647 Yamamoto Y, Chochi Y, Matsuyama H, Eguchi S, et al. (2007). Gain of 5p15.33 is associated with progression of bladder cancer. Oncology 72: 132-138. PMid:18025801 Zhu CQ, Cutz JC, Liu N, Lau D, et al. (2006). Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer. Br. J. Cancer 94: 1452-1459. PMid:16641908    PMCid:2361293 Zienolddiny S, Skaug V, Landvik NE, Ryberg D, et al. (2009). The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung. Carcinogenesis 30: 1368-1371. PMid:19465454